Literature DB >> 28699510

Cell Penetrating Peptides: A Promising Tool for the Cellular Uptake of Macromolecular Drugs.

Peipei Zhu1, Lan Jin1.   

Abstract

The lipid bilayer of the plasma membrane is a selective impermeable barrier for the internalization of most macromolecules. Cell penetrating peptides (CPPs) could cross the plasma membrane barrier to deliver various molecules into cells and are considered as a promising tool to deliver macromolecular drugs. However, the exact cellular uptake mechanisms of CPPs are still ambiguous. It was reported that the exact cellular uptake pathway was determined by numerous factors such as the amino acid sequences (hydrophobicity and net charge), extracellular CPP concentration, cargoes' properties, cell type and the temperature. No matter what kind of mechanisms, the electrostatic interaction between the positive charged amino acids and the membrane with negatively charged glycosaminoglycans (GAGs), especially heparan sulphate proteoglycans (HSPGs), was supposed to be the first crucial step for CPPs uptake. The first recognition triggers cytoskeletal remodeling via activating Rho/Rac GTPases and kinase C, followed by the cell surface microdomains changing, ligand binding and cellular uptake. This review briefly discusses the classification, structure-activity relationships, cellular uptake mechanisms and biomedical applications of CPPs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cell penetrating peptides; cellular uptake mechanisms; electrostatic interaction; heparan sulfate proteoglycans; macromolecule drugs; structure-activity relationships

Mesh:

Substances:

Year:  2018        PMID: 28699510     DOI: 10.2174/1389203718666170710115240

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  8 in total

1.  Canavanine versus arginine: Prospects for cell-penetrating peptides.

Authors:  Lindsey O Calabretta; Vienna M Thomas; Ronald T Raines
Journal:  Tetrahedron Lett       Date:  2022-05-06       Impact factor: 2.032

2.  BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.

Authors:  Ting Yu; Yingxian Shi; Xinyan Pan; Qiang Feng; Peng Wang; Shuling Song; Lilin Yang; Julun Yang
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

Review 3.  Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.

Authors:  Stefania Martucciello; Silvia Sposito; Carla Esposito; Gaetana Paolella; Ivana Caputo
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

4.  Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.

Authors:  Cuiling Zhang; Weigang Ren; Qingxin Liu; Zhikai Tan; Junwei Li; Chunyi Tong
Journal:  Drug Des Devel Ther       Date:  2019-04-04       Impact factor: 4.162

5.  Polyhistidine facilitates direct membrane translocation of cell-penetrating peptides into cells.

Authors:  Han-Jung Lee; Yue-Wern Huang; Shiow-Her Chiou; Robert S Aronstam
Journal:  Sci Rep       Date:  2019-06-28       Impact factor: 4.379

6.  Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.

Authors:  Jingping Geng; Xiangli Guo; Lidan Wang; Richard Q Nguyen; Fengqin Wang; Changbai Liu; Hu Wang
Journal:  Biomolecules       Date:  2020-02-02

7.  Coupling the Antimalarial Cell Penetrating Peptide TP10 to Classical Antimalarial Drugs Primaquine and Chloroquine Produces Strongly Hemolytic Conjugates.

Authors:  Luísa Aguiar; Arnau Biosca; Elena Lantero; Jiri Gut; Nuno Vale; Philip J Rosenthal; Fátima Nogueira; David Andreu; Xavier Fernàndez-Busquets; Paula Gomes
Journal:  Molecules       Date:  2019-12-12       Impact factor: 4.411

Review 8.  Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides.

Authors:  Minglu Hao; Lei Zhang; Pu Chen
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.